Discussing Perioperative Therapy In The CARMENA & PROBE Trials

Axel Bex M.D. Department of Urology
The Netherlands Cancer Institute
Amsterdam Discusses Perioperative Therapy In The CARMENA & PROBE Trials. At The Fourteenth European International Kidney Cancer Symposium on Mar 29, 2019.

Discussing Perioperative Therapy In The CARMENA & PROBE Trials

Tivozanib for RCC: Unpacking Efficacy, Safety, and Dose Optimization – Bradley McGregor, MD – Dana Farber

Renal Cell Carcinoma TiNivo-2 Study: Patient-Reported Outcomes in Treatment Post-ICI

VIDEO: FDA Approves Atezolizumab / Tecentriq Hybreza For Subcutaneous PD-(L)1 Cancer Immunotherapy in NSCLC

Discussing Perioperative Therapy In The CARMENA & PROBE Trials

Related Posts

Tivozanib for RCC: Unpacking Efficacy, Safety, and Dose Optimization – Bradley McGregor, MD – Dana Farber

Renal Cell Carcinoma TiNivo-2 Study: Patient-Reported Outcomes in Treatment Post-ICI

VIDEO: FDA Approves Atezolizumab / Tecentriq Hybreza For Subcutaneous PD-(L)1 Cancer Immunotherapy in NSCLC